Hashimoto, Etsuko
4 papers on CoChatORCID 0000-0002-0538-1709
Most cited papers
- Verified
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Harrison, S. A., Wong, V. W.-S., Okanoue, T., Bzowej, N., Vuppalanchi, R., Younes, Z., Kohli, A., Sarin, S., Caldwell, S. H., Alkhouri, N., et al. (2020) · Journal of Hepatology
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 497
- Verified
Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma
Yasui, K., Hashimoto, E., Komorizono, Y., Koike, K., Arii, S., Imai, Y., Shima, T., Kanbara, Y., Saibara, T., Mori, T., et al. (2011) · Clinical Gastroenterology and Hepatology
Liver Disease Diagnosis and TreatmentHepatocellular Carcinoma Treatment and Prognosis
Cited by 420
- Verified
Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
Hashimoto, E., Yatsuji, S., Tobari, M., Taniai, M., Torii, N., Tokushige, K., & Shiratori, K. (2009) · Journal of Gastroenterology
Liver Disease Diagnosis and TreatmentHepatocellular Carcinoma Treatment and Prognosis
Cited by 308
- Verified
Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey
Tokushige, K., Hashimoto, E., Horie, Y., Taniai, M., & Higuchi, S. (2011) · Journal of Gastroenterology
Hepatocellular Carcinoma Treatment and PrognosisLiver Disease Diagnosis and Treatment
Cited by 124
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free